Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Ladenburg Thalmann Started Coverage on Zynerba Pharma (ZYNE) Stock with $25.5 Target

London Zynerba Pharma ZYNE

Zynerba Pharma (ZYNE) Price Target & New Coverage by Ladenburg Thalmann

Ladenburg Thalmann has started its coverage on Zynerba Pharma (ZYNE), today Monday morning. The broker finds the stock of ZYNE attractive and has target price of $25.5 with “Buy” rating.

After the new initiation ZYNE is currently trading 0.00% lower at $0.00 as of 10:05 AM New York time. Zynerba Pharma’s stock is 0% over the last 200 days. It has underperformed the S&P 500 Index, which has surged 6.00% over the same time.

ZYNE Stock Chart

Zynerba Pharma (ZYNE) closed at $0 yesterday. A total of shares of the company’s stock traded hands. This is down from average of shares. Zynerba Pharma has a 52 week low of $0.00 and a 52 week high of $0. The company has a market cap of $ and a P/E ratio of 0.

Get the latest Zynerba Pharma (ZYNE) Stock Ratings at Octafinance. Completely free access to our Analyst Ratings Database for 6000+ stocks.

The post Ladenburg Thalmann Started Coverage on Zynerba Pharma (ZYNE) Stock with $25.5 Target appeared first on Octafinance.



This post first appeared on Octafinance – Financial News, Reports And Intell, please read the originial post: here

Share the post

Ladenburg Thalmann Started Coverage on Zynerba Pharma (ZYNE) Stock with $25.5 Target

×

Subscribe to Octafinance – Financial News, Reports And Intell

Get updates delivered right to your inbox!

Thank you for your subscription

×